Want to track RAPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rapt Therapeutics, Inc. (RAPT) Statistics
Valuation metrics
Market Cap 1.68B
Enterprise value 1.45B
Trailing P/E (ttm) -2.27
Forward P/E -21.38
PEG ratio 0.03
Price/Sales (ttm) -
Price/Book (mrq) 6.43
Enterprise Value/Revenue -
Enterprise Value/EBITDA -13.01
Overview
Shares outstanding 16.86M
Float 16.85M
Shares short 2.24M
% Held by insiders 0%
% Held by institutions 1.11%
Average volume (10 days) 3.1K
Average volume (90 days) 3.05M
Price summary
52-Week low 5.67
52-Week high 58.02
Beta 0.44
50-Day moving average 49.94
200-Day moving average 27.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 17 Jun 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.51%
Return on equity -0.85%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -111.66M
Net income to common (ttm) -105.64M
Diluted EPS (ttm) -11.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 157.34M
Total cash per share (mrq) 5.68
Total debt (mrq) 2.6M
Total Debt/Equity (mrq) 1.71
Current ratio (mrq) 12.04%
Book value per share (mrq) 9.02
Cash Flow
Cash flow statement -86.58M
Levered free cash flow (LFCF) -46.39M
